| Drug Name | Valdoxan (agomelatine) |
|---|---|
| Drug Class |
Anti-depressant
|
| Risk minimization type |
Healthcare provider guide
|
| Specialty (Theraputic area) |
Psychiatry
|
| Risk |
To improve awareness on the need for monitoring liver function during treatment and the contraindication od use with potent CYP 1A2 inhibitors |
| Health care provider guide |
|